文献速递新发突发、热带与寄生虫病

多样疟原虫基因型暴露塑造肯尼亚症状性疟疾风险:纵向分子流行病学研究

Exposure to Diverse Plasmodium falciparum Genotypes Shapes the Risk of Symptomatic Malaria in Incident and Persistent Infections: A Longitudinal Molecular Epidemiologic Study in Kenya.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究在肯尼亚西部开展14个月纵向队列,对186人的534次无症状和88次症状性恶性疟原虫感染进行pfama1和pfcsp扩增子深度测序,分析连续感染中寄生虫单倍型的重叠情况。结果显示,仅含新单倍型的偶发感染相比仅含复发单倍型的感染,症状性疟疾的比值比显著升高(OR: 3.24; 95%CI: 1.20-8.78),而混合或持续单倍型感染未见此关联。

要点

  • 仅新单倍型的偶发感染与症状性疟疾风险升高相关(OR: 3.24)。
  • 混合新发与复发单倍型感染未显示症状风险升高(OR: 0.64)。
  • 持续感染中混合单倍型与症状性疟疾无关联(OR: 0.77)。

核心结论

  • 仅含新单倍型的偶发感染相比仅含复发单倍型的感染,症状性疟疾的比值比升高(OR: 3.24; 95%CI: 1.20-8.78)。
  • 当单倍型在连续感染中持续存在时,未观察到上述关联。

研究设计与样本

  • 在肯尼亚西部开展14个月纵向队列研究。
  • 对186人的534次无症状和88次症状性感染,用pfama1和pfcsp扩增子深度测序评估连续感染间寄生虫单倍型重叠。

主要发现

  • 检测到109种pfcsp单倍型,每次感染分类为含新、复发或持续单倍型。
  • 仅新单倍型的偶发感染相比仅复发单倍型感染,症状性疟疾OR为3.24(95%CI: 1.20-8.78)。
  • 新发与复发混合单倍型感染OR为0.64(95%CI: 0.15-2.65)。
  • 持续感染中混合单倍型(持续伴新或复发)相比仅持续单倍型,OR为0.77(95%CI: 0.21-2.75)。
  • pfama1结果与pfcsp相似。

临床怎么用

  • 提示暴露于多样疟原虫基因型可能影响症状性疟疾风险,支持适应性免疫随暴露累积的概念。
  • 连续感染中单倍型持续存在时症状风险关联消失,提示免疫识别可能涉及既往暴露的单倍型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Repeated exposure to malaria infections could protect against symptomatic progression as people develop adaptive immunity to infections acquired over time. METHODS: We investigated how new, recurrent, and persistent Plasmodium falciparum infections were associated with the odds of developing symptomatic compared with asymptomatic malaria. Using a 14-month longitudinal cohort in Western Kenya, we used amplicon deep sequencing of 2 polymorphic genes (pfama1 and pfcsp) to assess overlap of parasite genotypes (represented by haplotypes) acquired within an individual's successive infections. We hypothesized infections with novel haplotypes would increase the odds of symptomatic malaria. RESULTS: After excluding initial infections, we observed 534 asymptomatic and 88 symptomatic infections across 186 people. We detected 109 pfcsp haplotypes, and each infection was classified as harboring novel, recurrent, or persistent haplotypes. Incident infections with only new haplotypes had higher odds of symptomatic malaria when compared with infections with only recurrent haplotypes [odds ratio (OR): 3.24; 95% confidence interval (CI), 1.20-8.78], but infections with both new and recurrent haplotypes (OR: 0.64; 95% CI: 0.15-2.65) did not. Assessing persistent infections, those with mixed (persistent with new or recurrent) haplotypes (OR: 0.77; 95% CI: 0.21-2.75) had no association with symptomatic malaria compared with infections with only persistent haplotypes. Results were similar for pfama1. CONCLUSIONS: These results confirm that incident infections with only novel haplotypes were associated with increased odds of symptomatic malaria compared with infections with only recurrent haplotypes but this relationship was not seen when haplotypes persisted over time in consecutive infections.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sumner KM, Freedman E, Mangeni JN, et al. Exposure to Diverse Plasmodium falciparum Genotypes Shapes the Risk of Symptomatic Malaria in Incident and Persistent Infections: A Longitudinal Molecular Epidemiologic Study in Kenya. Clin Infect Dis. 2021. PMID: 33904907. doi:10.1093/cid/ciab357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。